Table I.
Clinical and microbiological characteristics of the 9 cases of Trichomonas tenax detected in pleural effusion published in the literature since 1968.
| First author, year | Age, years | Sex | Underlying disease(s) | Immunosuppressive therapy | Coinfection pathogen | Treatment | Outcome | (Refs.) |
|---|---|---|---|---|---|---|---|---|
| Memik, 1968 | 87 | M | Chronic pulmonary disease | No | Bacteria | MTZ and TET | Clinical improvement | (15) |
| Ohkura et al, 1985 | 70 | M | Alcohol abuse | No | Bacteria | MTZ, CEF | Clinical improvement | (16) |
| Shiota et al, 1998 | 53 | M | Acromegaly rectal adenocarcinoma | Chemotherapy, corticotherapy and cobalt irradiation | Bacteria | MTZ | Clinical improvement | (17) |
| Porcheret et al, 2002 | 59 | M | Lung adenocarcinoma | Corticotherapy | Bacteria | MTZ, GEN and CIP | Death | (18) |
| Mallat et al, 2004 | 58 | M | Esophagus adenocarcinoma | No | Bacteria | MTZ, PTZ and GEN | Death | (19) |
| Bellanger et al, 2008 | 33 | F | Heart transplantation | Yes | Bacteria | MTZ and PTZ | Clinical improvement | (20) |
| Leterrier et al, 2012 | 67 | F | Glioblastoma high | Corticotherapy | Bacteria | MTZ | Death | (13) |
| Wu et al, 2021 | 16 | M | Cerebral palsy | No | Fungus | MTZ and VOR | Clinical improvement | (11) |
| Cai and Fang, 2022 | 69 | M | Cerebral infarction | No | Bacteria | MTZ and PTZ | Clinical improvement | (21) |
M, male; F, female; MTZ, metronidazole; TET, tetracycline; CEF, cephalotin; GEN, gentamicin; CIP, ciprofloxacin; PTZ, piperacillin-tazobactam; VOR, voriconazole.